nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—amyotrophic lateral sclerosis	0.647	1	CbGaD
Etodolac—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0452	CcSEcCtD
Etodolac—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0272	CcSEcCtD
Etodolac—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00673	0.0241	CcSEcCtD
Etodolac—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00635	0.0227	CcSEcCtD
Etodolac—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00586	0.021	CcSEcCtD
Etodolac—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00586	0.021	CcSEcCtD
Etodolac—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0197	CcSEcCtD
Etodolac—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0195	CcSEcCtD
Etodolac—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00479	0.0171	CcSEcCtD
Etodolac—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0167	CcSEcCtD
Etodolac—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0154	CcSEcCtD
Etodolac—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0148	CcSEcCtD
Etodolac—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0148	CcSEcCtD
Etodolac—Coma—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0144	CcSEcCtD
Etodolac—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0143	CcSEcCtD
Etodolac—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0137	CcSEcCtD
Etodolac—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00375	0.0134	CcSEcCtD
Etodolac—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0131	CcSEcCtD
Etodolac—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0128	CcSEcCtD
Etodolac—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00358	0.0128	CcSEcCtD
Etodolac—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0126	CcSEcCtD
Etodolac—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0122	CcSEcCtD
Etodolac—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0121	CcSEcCtD
Etodolac—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0119	CcSEcCtD
Etodolac—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0119	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0115	CcSEcCtD
Etodolac—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0102	CcSEcCtD
Etodolac—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00998	CcSEcCtD
Etodolac—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00991	CcSEcCtD
Etodolac—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00972	CcSEcCtD
Etodolac—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00953	CcSEcCtD
Etodolac—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0095	CcSEcCtD
Etodolac—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00941	CcSEcCtD
Etodolac—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00927	CcSEcCtD
Etodolac—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00927	CcSEcCtD
Etodolac—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00916	CcSEcCtD
Etodolac—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00905	CcSEcCtD
Etodolac—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00889	CcSEcCtD
Etodolac—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00871	CcSEcCtD
Etodolac—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00866	CcSEcCtD
Etodolac—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00862	CcSEcCtD
Etodolac—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00862	CcSEcCtD
Etodolac—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00847	CcSEcCtD
Etodolac—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00843	CcSEcCtD
Etodolac—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00829	CcSEcCtD
Etodolac—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00825	CcSEcCtD
Etodolac—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00797	CcSEcCtD
Etodolac—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00795	CcSEcCtD
Etodolac—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00793	CcSEcCtD
Etodolac—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00793	CcSEcCtD
Etodolac—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00789	CcSEcCtD
Etodolac—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00788	CcSEcCtD
Etodolac—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0075	CcSEcCtD
Etodolac—Chills—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00712	CcSEcCtD
Etodolac—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00709	CcSEcCtD
Etodolac—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00701	CcSEcCtD
Etodolac—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00681	CcSEcCtD
Etodolac—Tension—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00678	CcSEcCtD
Etodolac—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00676	CcSEcCtD
Etodolac—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00671	CcSEcCtD
Etodolac—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00647	CcSEcCtD
Etodolac—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00641	CcSEcCtD
Etodolac—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00638	CcSEcCtD
Etodolac—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00631	CcSEcCtD
Etodolac—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00623	CcSEcCtD
Etodolac—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00621	CcSEcCtD
Etodolac—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00619	CcSEcCtD
Etodolac—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00618	CcSEcCtD
Etodolac—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0061	CcSEcCtD
Etodolac—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00607	CcSEcCtD
Etodolac—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00598	CcSEcCtD
Etodolac—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00596	CcSEcCtD
Etodolac—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00588	CcSEcCtD
Etodolac—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00588	CcSEcCtD
Etodolac—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00586	CcSEcCtD
Etodolac—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00581	CcSEcCtD
Etodolac—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00575	CcSEcCtD
Etodolac—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00568	CcSEcCtD
Etodolac—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00564	CcSEcCtD
Etodolac—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00564	CcSEcCtD
Etodolac—Infection—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0056	CcSEcCtD
Etodolac—Shock—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00555	CcSEcCtD
Etodolac—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00552	CcSEcCtD
Etodolac—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0055	CcSEcCtD
Etodolac—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00545	CcSEcCtD
Etodolac—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00537	CcSEcCtD
Etodolac—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00527	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00514	CcSEcCtD
Etodolac—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0051	CcSEcCtD
Etodolac—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00506	CcSEcCtD
Etodolac—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00503	CcSEcCtD
Etodolac—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00501	CcSEcCtD
Etodolac—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00496	CcSEcCtD
Etodolac—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0049	CcSEcCtD
Etodolac—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00486	CcSEcCtD
Etodolac—Pain—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00482	CcSEcCtD
Etodolac—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00482	CcSEcCtD
Etodolac—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00465	CcSEcCtD
Etodolac—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00461	CcSEcCtD
Etodolac—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00448	CcSEcCtD
Etodolac—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00446	CcSEcCtD
Etodolac—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00446	CcSEcCtD
Etodolac—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00415	CcSEcCtD
Etodolac—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00404	CcSEcCtD
Etodolac—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00399	CcSEcCtD
Etodolac—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00386	CcSEcCtD
Etodolac—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00373	CcSEcCtD
Etodolac—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.001	0.00358	CcSEcCtD
Etodolac—Rash—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00355	CcSEcCtD
Etodolac—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00355	CcSEcCtD
Etodolac—Headache—Riluzole—amyotrophic lateral sclerosis	0.000986	0.00353	CcSEcCtD
Etodolac—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000935	0.00335	CcSEcCtD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000241	0.00327	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000239	0.00324	CbGpPWpGaD
Etodolac—UGT2B7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000238	0.00323	CbGpPWpGaD
Etodolac—UGT2B7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000235	0.00318	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000233	0.00316	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000232	0.00315	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000231	0.00313	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000223	0.00303	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000222	0.00301	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000221	0.00299	CbGpPWpGaD
Etodolac—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000219	0.00297	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000219	0.00297	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000219	0.00297	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000217	0.00294	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000215	0.00292	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000215	0.00291	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000215	0.00291	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000209	0.00284	CbGpPWpGaD
Etodolac—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000206	0.00279	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000205	0.00277	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000203	0.00274	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000202	0.00274	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000197	0.00267	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000197	0.00266	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000196	0.00266	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000195	0.00264	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000193	0.00262	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000191	0.00259	CbGpPWpGaD
Etodolac—UGT1A9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000191	0.00259	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000188	0.00254	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000186	0.00253	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000185	0.00251	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000183	0.00248	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000182	0.00247	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000182	0.00247	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000182	0.00247	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000182	0.00247	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000182	0.00247	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000181	0.00245	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000177	0.0024	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000177	0.0024	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000176	0.00238	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000174	0.00236	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000174	0.00235	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000172	0.00233	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000171	0.00232	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00017	0.00231	CbGpPWpGaD
Etodolac—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00017	0.00231	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00017	0.00231	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000167	0.00226	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000163	0.00221	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000162	0.00219	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000159	0.00216	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000159	0.00216	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000159	0.00215	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000158	0.00214	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000156	0.00211	CbGpPWpGaD
Etodolac—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000156	0.00211	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000155	0.0021	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000155	0.0021	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000152	0.00206	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000151	0.00204	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000151	0.00204	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000149	0.00201	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000148	0.00201	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000148	0.00201	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000148	0.00201	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000147	0.00199	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000146	0.00198	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000145	0.00197	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000145	0.00196	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000143	0.00193	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000141	0.00191	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00014	0.00189	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000139	0.00189	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000138	0.00187	CbGpPWpGaD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000138	0.00187	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000137	0.00185	CbGpPWpGaD
Etodolac—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000136	0.00184	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000136	0.00184	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000135	0.00183	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000134	0.00182	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000132	0.00179	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000132	0.00179	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000132	0.00179	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000131	0.00178	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00013	0.00177	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000128	0.00173	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000126	0.00171	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000126	0.0017	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000123	0.00167	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000121	0.00164	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000121	0.00164	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000121	0.00164	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000121	0.00164	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000118	0.00161	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000118	0.0016	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.0016	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000118	0.00159	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000117	0.00158	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000115	0.00156	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000115	0.00156	CbGpPWpGaD
Etodolac—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000115	0.00155	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000114	0.00155	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000113	0.00153	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000111	0.00151	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000111	0.0015	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000111	0.0015	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.00147	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000107	0.00145	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.00143	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000106	0.00143	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000103	0.00139	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000101	0.00136	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	9.99e-05	0.00135	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.82e-05	0.00133	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.66e-05	0.00131	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.59e-05	0.0013	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.59e-05	0.0013	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.55e-05	0.00129	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	9.35e-05	0.00127	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	9.32e-05	0.00126	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	9.22e-05	0.00125	CbGpPWpGaD
Etodolac—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	9.16e-05	0.00124	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	9.05e-05	0.00123	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	8.97e-05	0.00122	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.94e-05	0.00121	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	8.91e-05	0.00121	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.77e-05	0.00119	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	8.74e-05	0.00118	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	8.6e-05	0.00117	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	8.49e-05	0.00115	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.33e-05	0.00113	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.29e-05	0.00112	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.18e-05	0.00111	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.16e-05	0.00111	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	8.14e-05	0.0011	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	8.12e-05	0.0011	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.09e-05	0.0011	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.84e-05	0.00106	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.82e-05	0.00106	CbGpPWpGaD
Etodolac—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	7.76e-05	0.00105	CbGpPWpGaD
Etodolac—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	7.76e-05	0.00105	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	7.69e-05	0.00104	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.67e-05	0.00104	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	7.62e-05	0.00103	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	7.62e-05	0.00103	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	7.57e-05	0.00103	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	7.5e-05	0.00102	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	7.26e-05	0.000984	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.24e-05	0.000981	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.19e-05	0.000975	CbGpPWpGaD
Etodolac—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	7.1e-05	0.000962	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	7.07e-05	0.000957	CbGpPWpGaD
Etodolac—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	6.94e-05	0.00094	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	6.93e-05	0.00094	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.88e-05	0.000932	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.88e-05	0.000932	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.83e-05	0.000925	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	6.72e-05	0.000911	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.62e-05	0.000897	CbGpPWpGaD
Etodolac—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.6e-05	0.000894	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.45e-05	0.000874	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	6.35e-05	0.000861	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	6.35e-05	0.000861	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.3e-05	0.000853	CbGpPWpGaD
Etodolac—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	6.28e-05	0.00085	CbGpPWpGaD
Etodolac—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	6.2e-05	0.000841	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	6.15e-05	0.000834	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.13e-05	0.000831	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	6.11e-05	0.000828	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.92e-05	0.000803	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	5.81e-05	0.000787	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.62e-05	0.000761	CbGpPWpGaD
Etodolac—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	5.61e-05	0.00076	CbGpPWpGaD
Etodolac—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	5.59e-05	0.000758	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.56e-05	0.000754	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.54e-05	0.00075	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.4e-05	0.000732	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.26e-05	0.000712	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	5.22e-05	0.000707	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	5.18e-05	0.000702	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	5.08e-05	0.000688	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.02e-05	0.00068	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	4.85e-05	0.000657	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.79e-05	0.000649	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.7e-05	0.000637	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	4.59e-05	0.000622	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.58e-05	0.00062	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.42e-05	0.000599	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.42e-05	0.000599	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.4e-05	0.000596	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.38e-05	0.000593	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.34e-05	0.000588	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.25e-05	0.000576	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.07e-05	0.000552	CbGpPWpGaD
Etodolac—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	4.01e-05	0.000544	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.98e-05	0.00054	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.93e-05	0.000532	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.92e-05	0.000532	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.9e-05	0.000528	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.85e-05	0.000521	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.8e-05	0.000515	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.74e-05	0.000507	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.63e-05	0.000493	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	3.62e-05	0.000491	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.57e-05	0.000484	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.55e-05	0.000481	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.49e-05	0.000473	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.48e-05	0.000472	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.38e-05	0.000458	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.31e-05	0.000448	CbGpPWpGaD
Etodolac—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.22e-05	0.000437	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.21e-05	0.000435	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.14e-05	0.000425	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-05	0.000417	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.04e-05	0.000412	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.94e-05	0.000398	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.93e-05	0.000396	CbGpPWpGaD
Etodolac—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.92e-05	0.000396	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	2.87e-05	0.000389	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.7e-05	0.000365	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.67e-05	0.000362	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.64e-05	0.000357	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	2.5e-05	0.000339	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	2.5e-05	0.000339	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.48e-05	0.000336	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.48e-05	0.000336	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.41e-05	0.000326	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.14e-05	0.00029	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-05	0.000286	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.04e-05	0.000276	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.01e-05	0.000273	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.97e-05	0.000267	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.97e-05	0.000267	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000262	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.74e-05	0.000236	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.73e-05	0.000235	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.71e-05	0.000232	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.65e-05	0.000223	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.62e-05	0.000219	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000216	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.42e-05	0.000192	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.4e-05	0.000189	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.32e-05	0.000178	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.31e-05	0.000177	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.3e-05	0.000177	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.07e-05	0.000145	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.97e-06	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.34e-06	9.95e-05	CbGpPWpGaD
